Hyperoxia induces S-phase cell-cycle arrest and p21(Cip1/Waf1)- independent Cdk2 inhibition in human carcinoma T47D-H3 cells

Experimental Cell Research

Volumn 256, Issue 2, 2000, Pages 347-357

  Bilodeau, Jean François ^a   Faure, Robert ^a   Piedboeuf, Bruno ^a   Mirault, Marc Edouard ^a  

^a UNIVERSITÉ LAVAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN DEPENDENT KINASE 2; PROTEIN P21; PROTEIN P27; TRANSCRIPTION FACTOR E2F;

ARTICLE; BREAST CARCINOMA; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HYPEROXIA; MITOSIS INHIBITION; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION;

EID: 0034193248     PISSN: 00144827     EISSN: None     Source Type: Journal    
DOI: 10.1006/excr.2000.4844     Document Type: Article

References (77)

1. Frank L., Massaro D. Oxygen toxicity. Am. J. Med. 69:1980;117-126.
2. Clement A., Hübscher U., Junod A. F. Effects of hyperoxia on DNA synthesis in cultured porcine aortic endothelial cells. J. Appl. Physiol. 59:1985;1110-1116.
3. Junod A. F., Clement A., Jornot L., Petersen H. Differential effects of hyperoxia and hydrogen peroxide on thymidine kinase and adenosine kinase activities of cultured endothelial cells. Biochim. Biophys. Acta. 847:1985;20-24.
4. Jornot L., Mirault M. E., Junod A. F. Protein synthesis in hyperoxic endothelial cells: evidence for translational defect. J. Appl. Physiol. 63:1987;457-464.
5. Junod A. F. Effects of oxygen intermediates on cellular functions. Am. Rev. Respir. Dis. 135:1987;S32-S34.
6. Zweier J. L., Duke S. S., Kuppusamy P., Sylvester J. T., Gabrielson E. W. Electron paramagnetic resonance evidence that cellular oxygen toxicity is caused by the generation of superoxide and hydroxyl free radicals. FEBS Lett. 252:1989;12-16.
7. O'Connell M. J., Webster N. R. Hyperoxia and salicylate metabolism in rats. J. Pharm. Pharmacol. 42:1990;205-206.
8. Sanders S. P., Zweier J. L., Kuppusamy P., Harrison S. J., Bassett D. J., Gabrielson E. W., Sylvester J. T. Hyperoxic sheep pulmonary microvascular endothelial cells generate free radicals via mitochondrial electron transport. J. Clin. Invest. 91:1993;46-52.
9. Guidot D. M., McCord J. M., Wright R. M., Repine J. E. Absence of electron transport (Rho 0 state) restores growth of a manganese-superoxide dismutase-deficient Saccharomyces cerevisiae in hyperoxia: Evidence for electron transport as a major source of superoxide generation in vivo. J. Biol. Chem. 268:1993;26699-26703.
10. Cacciuttolo M. A., Trinh L., Lumpkin J. A., Rao G. Hyperoxia induces DNA damage in mammalian cells. Free Radicals Biol. Med. 14:1993;267-276.
11. Kim H. S., Park Y. W., Kasai H., Nishimura S., Park C. W., Choi K. H., Chung M. H. Induction of E. coli oh8Gua endonuclease by oxidative stress: Its significance in aerobic life. Mutat. Res. 363:1996;115-123.
12. Rawling J. M., ApSimon M. M., Kirkland J. B. Lung poly(ADP-ribose) and NAD+ concentrations during hyperoxia and niacin deficiency in the Fischer-344 rat. Free Radicals Biol. Med. 20:1996;865-871.
13. Vaziri H., West M. D., Allsopp R. C., Davison T. S., Wu Y. S., Arrowsmith C. H., Poirier G. G., Benchimol S. ATM-dependent telomere loss in aging human diploid fibroblasts and DNA damage lead to the post-translational activation of p53 protein involving poly(ADP-ribose) polymerase. Embo J. 16:1997;6018-6033.
14. O'Reilly M. A., Staversky R. J., Stripp B. R., Finkelstein J. N. Exposure to hyperoxia induces p53 expression in mouse lung epithelium. Am. J. Respir. Cell Mol. Biol. 18:1998;43-50.
15. Kong X. J., Lee S. L., Lanzillo J. J., Fanburg B. L. Cu,Zn superoxide dismutase in vascular cells: Changes during cell cycling and exposure to hyperoxia. Am. J. Physiol. 264:1993;L365-375.
16. Michel C., Vincent F., Duval C., Poelman M. C., Adolphe M. Toxic effects and detection of oxygen free radicals on cultured articular chondrocytes generated by menadione. Free Radical Res. Commun. 17:1992;279-289.
17. Faure R., Vincent M., Dufour M., Shaver A., Posner B. I. Arrest at the G2/M transition of the cell cycle by protein-tyrosine phosphatase inhibition: Studies on a neuronal and a glial cell line. J. Cell. Biochem. 59:1995;389-401.
18. Barford D., Jia Z., Tonks N. K. Protein tyrosine phosphatases take off. Nat. Struct. Biol. 2:1995;1043-1053.
19. Corroyer S., Maitre B., Cazals V., Clement A. Altered regulation of G1 cyclins in oxidant-induced growth arrest of lung alveolar epithelial cells. Accumulation of inactive cyclin E-DCK2 complexes. J. Biol. Chem. 271:1996;25117-25125.
20. Reed S. I. Control of the G1/S transition. Cancer Surv. 29:1997;7-23.
21. Hengst L., Reed S. I. Inhibitors of the Cip/Kip family. Curr. Top. Microbiol. Immunol. 227:1998;25-41.
22. Painter R. B., Young B. R. Radiosensitivity in ataxia-telangiectasia: A new explanation. Proc. Natl. Acad. Sci. USA. 77:1980;7315-7317.
23. Larner J. M., Lee H., Hamlin J. L. Radiation effects on DNA synthesis in a defined chromosomal replicon. Mol. Cell. Biol. 14:1994;1901-1908.
24. Paulovich A. G., Hartwell L. H. A checkpoint regulates the rate of progression through S phase in S. cerevisiae in response to DNA damage. Cell. 82:1995;841-847.
25. Savitsky K., Bar-Shira A., Gilad S., Rotman G., Ziv Y., Vanagaite L., Tagle D. A., Smith S., Uziel T., Sfez S. A single ataxia telangiectasia gene with a product similar to PI-3 kinase. Science. 268:1995;1749-1753.
26. Xiong Y., Zhang H., Beach D. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA. Cell. 71:1992;505-514.
27. Li R., Waga S., Hannon G. J., Beach D., Stillman B. Differential effects by the p21 CDK inhibitor on PCNA-dependent DNA replication and repair. Nature. 371:1994;534-537.
28. Waga S., Hannon G. J., Beach D., Stillman B. The p21 inhibitor of cyclin-dependent kinases controls DNA replication by interaction with PCNA [see comments]. Nature. 369:1994;574-578.
29. Pines J. p21 inhibits cyclin shock. Nature. 369:1994;520-521.
30. Russo T., Zambrano N., Esposito F., Ammendola R., Cimino F., Fiscella M., Jackman J., PM O. C., Anderson C. W., Appella E. A p53-independent pathway for activation of WAF1/CIP1 expression following oxidative stress. J. Biol. Chem. 270:1995;29386-29391.
31. Wyllie F. S., Haughton M. F., Bond J. A., Rowson J. M., Jones C. J., Wynford-Thomas D. S phase cell-cycle arrest following DNA damage is independent of the p53/p21(WAF1) signalling pathway. Oncogene. 12:1996;1077-1082.
32. Xie G., Habbersett R. C., Jia Y., Peterson S. R., Lehnert B. E., Bradbury E. M., D'Anna J. A. Requirements for p53 and the ATM gene product in the regulation of G1/S and S phase checkpoints. Oncogene. 16:1998;721-736.
33. Petrocelli T., Poon R., Drucker D. J., Slingerland J. M., Rosen C. F. UVB radiation induces p21Cip1/WAF1 and mediates G1 and S phase checkpoints. Oncogene. 12:1996;1387-1396.
34. Wosikowski K., Regis J. T., Robey R. W., Alvarez M., Buters J. T., Gudas J. M., Bates S. E. Normal p53 status and function despite the development of drug resistance in human breast cancer cells. Cell Growth Differ. 6:1995;1395-1403.
35. Buckley M. F., Sweeney K. J., Hamilton J. A., Sini R. L., Manning D. L., Nicholson R. I., deFazio A., Watts C. K., Musgrove E. A., Sutherland R. L. Expression and amplification of cyclin genes in human breast cancer. Oncogene. 8:1993;2127-2133.
36. Musgrove E. A., Swarbrick A., Lee C. S., Cornish A. L., Sutherland R. L. Mechanisms of cyclin-dependent kinase inactivation by progestins. Mol. Cell. Biol. 18:1998;1812-1825.
37. Fiddes R. J., Janes P. W., Sivertsen S. P., Sutherland R. L., Musgrove E. A., Daly R. J. Inhibition of the MAP kinase cascade blocks heregulin-induced cell cycle progression in T-47D human breast cancer cells. Oncogene. 16:1998;2803-2813.
38. Mirault M.-E., Tremblay A., Beaudouin N., Tremblay M. Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants. J. Biol. Chem. 266:1991;20752-20760.
39. Mirault M.-E., Tremblay A., Lavoie L., Tremblay M., Beaudoin N. Transgenic expression of glutathione peroxidase in human breast cells: Increased resistance to clastogenic oxidants. Jesaitis A. J., Dratz E. A. The Molecular Basis of Oxidative Damage by Leukocytes. 1992;303-306 CRC Press, Boca Raton.
40. Mehlen P., Kretz Remy C., Briolay J., Fostan P., Mirault M. E., Arrigo A. P. Intracellular reactive oxygen species as apparent modulators of heat-shock protein 27 (hsp27) structural organization and phosphorylation in basal and tumour necrosis factor alpha-treated T47D human carcinoma cells. Biochem. J. 312:1995;367-375.
41. Kretz-Remy C., Mehlen P., Mirault M. E., Arrigo A. P. Inhibition of I kappa B-alpha phosphorylation and degradation and subsequent NF-kappa B activation by glutathione peroxidase overexpression. J. Cell Biol. 133:1996;1083-1093.
42. Legault J., Tremblay A., Ramotar D., Mirault M.-E. Clusters of S1 nuclease-hypersensitive sites induced in vivo by DNA damage. Mol. Cell. Biol. 17:1997;5437-5452.
43. Ormerod M. G., Kubbies M. Cell cycle analysis of asynchronous cell populations by flow cytometry using bromodeoxyuridine label and Hoechst-propidium iodide stain. Cytometry. 13:1992;678-685.
44. Beisker W., Dolbeare F., Gray J. W. An improved immunocytochemical procedure for high-sensitivity detection of incorporated bromodeoxyuridine. Cytometry. 8:1987;235-239.
45. Lambert R. D., Dufour M., Blouin L. Rabbit embryo-fetal fluid decreases the cell cycle activities of DU-145 cells. Cell. Prolif. 25:1992;141-153.
46. Denizot F., Lang R. Rapid colorimetric assay for cell growth and survival: Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods. 89:1986;271-277.
47. Piedboeuf B., Johnston C. J., Watkins R. H., Hudak B. B., Lazo J. S., Cherian M. G., Horowitz S. Increased expression of tissue inhibitor of metalloproteinases (TIMP-I) and metallothionein in murine lungs after hyperoxic exposure. Am. J. Resp. Cell Mol. Biol. 10:1994;123-132.
48. Bilodeau J.-F., Mirault M.-E. Increased resistance of GPx-1 transgenic mice to tumor promoter-induced loss of glutathione peroxidase activity in skin. Int. J. Cancer. 80:1999;863-867.
49. Higashi H., Suzuki-Takahashi I., Taya Y., Segawa K., Nishimura S., Kitagawa M. Differences in substrate specificity between Cdk2-cyclin A and Cdk2-cyclin E in vitro. Biochem. Biophys. Res. Commun. 216:1995;520-525.
50. Zhang H., Xiong Y., Beach D. Proliferating cell nuclear antigen and p21 are components of multiple cell cycle kinase complexes. Mol. Biol. Cell. 4:1993;897-906.
51. Zhang H., Hannon G. J., Casso D., Beach D. p21 is a component of active cell cycle kinases. Cold Spring Harb. Symp. Quant. Biol. 59:1994;21-29.
52. Guy G. R., Cairns J., Ng S. B., Tan Y. H. Inactivation of a redox-sensitive protein phosphatase during the early events of tumor necrosis factor/interleukin-1 signal transduction. J. Biol. Chem. 268:1993;2141-2148.
53. Gu Y., Rosenblatt J., Morgan D. O. Cell cycle regulation of CDK2 activity by phosphorylation of Thr160 and Tyr15. EMBO J. 11:1992;3995-4005.
54. Solomon M. J. Activation of the various cyclin/cdc2 protein kinases. Curr. Opin. Cell Biol. 5:1993;180-186.
55. Waga S., Stillman B. The DNA replication fork in eukaryotic cells. Annu. Rev. Biochem. 67:1998;721-751.
56. Waga S., Stillman B. Cyclin-dependent kinase inhibitor p21 modulates the DNA primer-template recognition complex. Mol. Cell Biol. 18:1998;4177-4187.
57. Krek W., Xu G., Livingston D. M. Cyclin A-kinase regulation of E2F-1 DNA binding function underlies suppression of an S phase checkpoint. Cell. 83:1995;1149-1158.
58. Streuli M., Krueger N. X., Thai T., Tang M., Saito H. Distinct functional roles of the two intracellular phosphatase like domains of the receptor-linked protein tyrosine phosphatases LCA and LAR. EMBO J. 9:1990;2399-2407.
59. Bjerkvig R., Thorsen J., Svendsen E., Holmsen H., Thorsen T. Effects of hyperoxia on human endothelial cell proliferation and morphology in vitro. Undersea Biomed. Res. 19:1992;415-426.
60. Nigro J. M., Baker S. J., Preisinger A. C., Jessup J. M., Hostetter R., Cleary K., Bigner S. H., Davidson N., Baylin S., Devilee P. Mutations in the p53 gene occur in diverse human tumour types. Nature. 342:1989;705-708.
61. WAF/CIP1 during hyperoxia. Am. J. Respir. Cell Mol. Biol. 18:1998;179-187.
62. Ohtsubo M., Theodoras A. M., Schumacher J., Roberts J. M., Pagano M. Human cyclin E, a nuclear protein essential for the G1-to-S phase transition. Mol. Cell Biol. 15:1995;2612-2624.
63. Won K. A., Reed S. I. Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E. Embo J. 15:1996;4182-4193.
64. Dulic V., Kaufmann W. K., Wilson S. J., Tlsty T. D., Lees E., Harper J. W., Elledge S. J., Reed S. I. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell. 76:1994;1013-1023.
65. D'Anna J. A., Valdez J. G., Habbersett R. C., Crissman H. A. Association of G1/S-phase and late S-phase checkpoints with regulation of cyclin-dependent kinases in Chinese hamster ovary cells. Radiat. Res. 148:1997;260-271.
66. CIP1. J. Cell. Biol. 130:1995;755-769.
67. Krek W., Ewen M. E., Shirodkar S., Arany Z., Kaelin W. G. Jr., Livingston D. M. Negative regulation of the growth-promoting transcription factor E2F-1 by a stably bound cyclin A-dependent protein kinase. Cell. 78:1994;161-172.
68. Maki C. G., Howley P. M. Ubiquitination of p53 and p21 is differentially affected by ionizing and UV radiation. Mol. Cell Biol. 17:1997;355-363.
69. Rousseau D., Cannella D., Boulaire J., Fitzgerald P., Fotedar A., Fotedar R. Growth inhibition by CDK-cyclin and PCNA binding domains of p21 occurs by distinct mechanisms and is regulated by ubiquitin-proteasome pathway. Oncogene. 18:1999;4313-4325.
70. Tassan J. P., Schultz S. J., Bartek J., Nigg E. A. Cell cycle analysis of the activity, subcellular localization, and subunit composition of human CAK (CDK-activating kinase). J. Cell Biol. 127:1994;467-478.
71. Posner B. I., Faure R., Burgess J. W., Bevan A. P., Lachance D., Zhang-Sun G., Fantus I. G., Ng J. B., Hall D. A., Soo Lum B., Shaver A. Peroxovanadium compounds: A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics. J. Biol. Chem. 269:1994;4596-4604.
72. Kleinberger-Doron N., Shelah N., Capone R., Gazit A., Levitzki A. Inhibition of cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase. Exp. Cell Res. 241:1998;340-351.
73. Hoffmann I., Draetta G., Karsenti E. Activation of the phosphatase activity of human cdc25A by a cdk2-cyclin E dependent phosphorylation at the G1/S transition. EMBO J. 13:1994;4302-4310.
74. Lammer C., Wagerer S., Saffrich R., Mertens D., Ansorge W., Hoffmann I. The cdc25B phosphatase is essential for the G2/M phase transition in human cells. J. Cell Sci. 111:1998;2445-2453.
75. Bresnahan W. A., Boldogh I., Ma T., Albrecht T., Thompson E. A. Cyclin E/Cdk2 activity is controlled by different mechanisms in the G0 and G1 phases of the cell cycle. Cell. Growth Differ. 7:1996;1283-1290.
76. Shenberger J. S., Dixon P. S. Oxygen induces S-phase growth arrest and increases p53 and p21(WAF1/CIP1) expression in human bronchial smooth-muscle cells. Am. J. Respir. Cell Mol. Biol. 21:1999;395-402.
77. Gaulin, J. F, Fiset, A, Fortier, S, and, Faure, R. Characterization of Cdk2-cyclin E complexes in plasma membrane and endosomes of liver parenchyma: Insulin-dependent regulation. Submitted.